NYSEMKT: IGCIgc Pharma Inc Stock Ownership - Who owns Igc Pharma?
Insider buying vs selling
Have Igc Pharma Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Claudia Grimaldi | PFO | 2026-06-30 | 2,048,378 | $0.27 | $553.06kBuy |
| Ram Mukunda | CEO | 2026-06-30 | 2,226,475 | $0.27 | $601.15kBuy |
| Claudia Grimaldi | PFO | 2026-04-01 | 138,462 | $0.26 | $36.00kBuy |
| Ram Mukunda | CEO | 2026-04-01 | 323,077 | $0.26 | $84.00kBuy |
IGC insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when IGC insiders and whales buy or sell their stock.
IGC Shareholders
What type of owners hold Igc Pharma Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Ram Mukunda | 7.94% | 8,211,314 | $2.30M | Insider |
| Bradbury Strategic Investment Fund A Cayman Islands Registration No Cr359857 | 4.84% | 5,000,000 | $1.40M | Insider |
| Claudia Grimaldi | 3.31% | 3,421,092 | $957.91k | Insider |
| James P. Moran | 2.11% | 2,178,137 | $609.88k | Insider |
| Richard K. Prins | 1.49% | 1,541,251 | $431.55k | Insider |
| Db Zwirn Co LP | 1.44% | 1,485,404 | $415.91k | Insider |
| Ranga C. Krishna | 1.03% | 1,068,461 | $299.17k | Insider |
| Steven Michael Oliveira | 0.75% | 772,196 | $216.21k | Insider |
| Sudhakar V. Shenoy | 0.67% | 695,000 | $194.60k | Insider |
| Ranga Krishna | 0.45% | 470,000 | $131.60k | Insider |
IGC vs Biotech Stocks
Igc Pharma Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.